References
Reishi
1. Wang X, Lin Z. Immunomodulating effect of Ganoderma (Lingzhi) and possible mechanism. Ganoderma and Health: Pharmacology and Clinical Application. 2019:1-37.
2. Cheng CH, Leung AY, Chen CF. The effects of two different ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells. Nutrition and cancer. 2010 Jun 25;62(5):648-58.
3. Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, Duan W. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. International immunopharmacology. 2006 Mar 1;6(3):499-508.
4. Zhang Y, Lin ZC, Hu Y, Wang FZ. Effect of Ganoderma lucidum capsules on T lymphocyte subsets in football players on "living high− training low". British journal of sports medicine. 2008 Oct 1;42(10):819-22.
5. Bhardwaj N, Katyal P, K Sharma A. Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Recent patents on inflammation & allergy drug discovery. 2014 May 1;8(2):104-17.
6. Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. Journal of medicinal food. 2005 Mar 1;8(1):53-8.
7. Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore powder of Ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: a pilot clinical trial. Evidence-Based Complementary and Alternative Medicine. 2012 Oct;2012.
8. Yao C, Wang Z, Jiang H, Yan R, Huang Q, Wang Y, Xie H, Zou Y, Yu Y, Lv L. Ganoderma lucidum promotes sleep through a gut microbiota-dependent and serotonin-involved pathway in mice. Scientific reports. 2021 Jul 1;11(1):13660.
9. Jin H, Song C, Zhao Z, Zhou G. Ganoderma lucidum polysaccharide, an extract from ganoderma lucidum, exerts suppressive effect on cervical cancer cell malignancy through mitigating epithelial-mesenchymal and JAK/STAT5 signaling pathway. Pharmacology. 2020 Jul 23;105(7-8):461-70.
10. Jiao C, Chen W, Tan X, Liang H, Li J, Yun H, He C, Chen J, Ma X, Xie Y, Yang BB. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. Journal of ethnopharmacology. 2020 Jan 30;247:112256.
11. Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W. Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway. Molecular medicine reports. 2018 Jan 1;17(1):147-57.
12. Liu X, Xu Y, Li Y, Pan Y, Sun Z, Zhao S, Hou Y. Ganoderma lucidum fruiting body extracts inhibit colorectal cancer by inducing apoptosis, autophagy, and G0/G1 phase cell cycle arrest in vitro and in vivo. American journal of translational research. 2020;12(6):2675.
13. Jin X, Beguerie JR, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews. 2016(4).
14. Chan SW, Tomlinson B, Chan P, Lam CW. The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Pharmaceutical biology. 2021 Jan 1;59(1):1159-69.
15. Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum ('Lingzhi'), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. British Journal of Nutrition. 2004 Feb;91(2):263-9.
16. Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database of Systematic Reviews. 2015(2).
17. Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Scientific reports. 2016 Aug 11;6(1):29540.
Lion's Mane
18. Chiu CH, Chyau CC, Chen CC, Lee LY, Chen WP, Liu JL, Lin WH, Mong MC. Erinacine A-enriched Hericium erinaceus mycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice. International journal of molecular sciences. 2018 Jan 24;19(2):341.
19. Ryu S, Kim HG, Kim JY, Kim SY, Cho KO. Hericium erinaceus extract reduces anxiety and depressive behaviors by promoting hippocampal neurogenesis in the adult mouse brain. Journal of medicinal food. 2018 Feb 1;21(2):174-80.
20. Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research. 2010;31(4):231-7.
21. Chong PS, Fung ML, Wong KH, Lim LW. Therapeutic potential of Hericium erinaceus for depressive disorder. International journal of molecular sciences. 2020 Jan;21(1):163.
22. Zhang C, Li J, Hu C, Wang J, Zhang J, Ren Z, Song X, Jia L. Antihyperglycaemic and organic protective effects on pancreas, liver and kidney by polysaccharides from Hericium erinaceus SG-02 in streptozotocin-induced diabetic mice. Scientific Reports. 2017 Sep 7;7(1):10847.
23. Lee SK, Ryu SH, Turk A, Yeon SW, Jo YH, Han YK, Hwang BY, Lee KY, Lee MK. Characterization of α-glucosidase inhibitory constituents of the fruiting body of lion's mane mushroom (Hericium erinaceus). Journal of Ethnopharmacology. 2020 Nov 15;262:113197.
24. Lee SK, Ryu SH, Turk A, Yeon SW, Jo YH, Han YK, Hwang BY, Lee KY, Lee MK. Characterization of α-glucosidase inhibitory constituents of the fruiting body of lion's mane mushroom (Hericium erinaceus). Journal of Ethnopharmacology. 2020 Nov 15;262:113197.
25. Tsai-Teng T, Chin-Chu C, Li-Ya L, Wan-Ping C, Chung-Kuang L, Chien-Chang S, Chi-Ying HF, Chien-Chih C, Shiao YJ. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice. Journal of biomedical science. 2016 Dec;23(1):1-2.
26. Li IC, Chang HH, Lin CH, Chen WP, Lu TH, Lee LY, Chen YW, Chen YP, Chen CC, Lin DP. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Frontiers in aging neuroscience. 2020 Jun 3;12:155.
27. Hiwatashi K, Kosaka Y, Suzuki N, Hata K, Mukaiyama T, Sakamoto K, Shirakawa H, Komai M. Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet. Bioscience, biotechnology, and biochemistry. 2010 Jul 23;74(7):1447-51.
28. Rahman MA, Abdullah N, Aminudin N. Inhibitory effect on in vitro LDL oxidation and HMG Co-A reductase activity of the liquid-liquid partitioned fractions of Hericium erinaceus (Bull.) Persoon (lion's mane mushroom). BioMed research international. 2014 May 13;2014.
29. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E. Cytokine levels after consumption of a medicinal Agaricus blazei murill‐based mushroom extract, AndoSan™, in patients with Crohn's disease and ulcerative colitis in a randomized single‐blinded placebo‐controlled study. Scandinavian journal of immunology. 2016 Dec;84(6):323-31.
30. Diling C, Xin Y, Chaoqun Z, Jian Y, Xiaocui T, Jun C, Ou S, Yizhen X. Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota. Oncotarget. 2017 Oct 10;8(49):85838.
Maitake
31. Namba H. Maitake D-fraction: healing and preventive potential for cancer. Journal of Orthomolecular Medicine. 1997;12(1):43-9.
32. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Alternative Medicine Review. 2002 Jun 1;7(3):236-9.
33. Alonso EN, Orozco M, Nieto AE, Balogh GA. Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells. Journal of medicinal food. 2013 Jul 1;16(7):602-17.
34. Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Experimental Biology and Medicine. 2001 Sep;226(8):758-65.
35. Sato M, Tokuji Y, Yoneyama S, Fujii-Akiyama K, Kinoshita M, Chiji H, Ohnishi M. Effect of dietary maitake (Grifola frondosa) mushrooms on plasma cholesterol and hepatic gene expression in cholesterol-fed mice. Journal of oleo science. 2013;62(12):1049-58.
36. Aoki H, Hanayama M, Mori K, Sato R. Grifola frondosa (Maitake) extract activates PPARδ and improves glucose intolerance in high-fat diet-induced obese mice. Bioscience, Biotechnology, and Biochemistry. 2018 Sep 2;82(9):1550-9.
37. Aranaz P, Peña A, Vettorazzi A, Fabra MJ, Martínez-Abad A, López-Rubio A, Pera J, Parladé J, Castellari M, Milagro FI, González-Navarro CJ. Grifola frondosa (Maitake) extract reduces fat accumulation and improves health span in C. elegans through the DAF-16/FOXO and SKN-1/NRF2 signalling pathways. Nutrients. 2021 Nov 7;13(11):3968.
38. Chen YH, Lee CH, Hsu TH, Lo HC. Submerged-culture mycelia and broth of the maitake medicinal mushroom Grifola frondosa (higher basidiomycetes) alleviate type 2 diabetes-induced alterations in immunocytic function. International Journal of Medicinal Mushrooms. 2015;17(6).
39. Hong L, Xun M, Wutong W. Anti‐diabetic effect of an α‐glucan from fruit body of maitake (Grifola frondosa) on KK‐Ay mice. Journal of Pharmacy and Pharmacology. 2007 Apr;59(4):575-82.
40. Szydłowska-Tutaj M, Szymanowska U, Tutaj K, Domagała D, Złotek U. Influence of Addition of Dried Maitake and Enoki Mushrooms on Antioxidant, Potentially Anti-Inflammatory, and Anti-Cancer Properties of Enriched Pasta. Applied Sciences. 2023 Jul 14;13(14):8183.
41. Garcia-Lafuentea A, Moro C, Villares A, Guillamon E, A Rostagno M, D'Arrigo M, Alfredo Martinez J. Mushrooms as a source of anti-inflammatory agents. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2010 Jun 1;9(2):125-41.
Turkey Tail
42. Janjušević L, Karaman M, Šibul F, Tommonaro G, Iodice C, Jakovljević D, Pejin B. The lignicolous fungus Trametes versicolor (L.) Lloyd (1920): a promising natural source of antiradical and AChE inhibitory agents. J Enzyme Inhib Med Chem. 2017 Dec;32(1):355-362.
43. Pérez-Cano FJ, Castell M. Flavonoids, Inflammation and Immune System. Nutrients. 2016 Oct 21;8(10):659.
44. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016 Mar 15;8(3):167.
45. Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML, Standish LJ. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res. 2011 Nov 1;17(21):6742-53.
46. Saleh MH, Rashedi I, Keating A. Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide. Front Immunol. 2017 Sep 6;8:1087.
47. Roca-Lema D, Martinez-Iglesias O, de Ana Portela CF, Rodríguez-Blanco A, Valladares-Ayerbes M, Díaz-Díaz A, Casas-Pais A, Prego C, Figueroa A. In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes versicolor and Grifola frondosa in colon cancer cells. International journal of medical sciences. 2019;16(2):231.
48. Awadasseid A, Hou J, Gamallat Y, Xueqi S, Eugene KD, Musa Hago A, Bamba D, Meyiah A, Gift C, Xin Y. Purification, characterization, and antitumor activity of a novel glucan from the fruiting bodies of Coriolus Versicolor. PLoS One. 2017 Feb 8;12(2):e0171270.
49. Ma Y, Wu X, Yu J, Zhu J, Pen X, Meng X. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis. Oncotarget. 2017 Jul 6;8(51):89108-89118.
50. Stamets P. Trametes versicolor (Turkey Tail Mushrooms) and the treatment of breast cancer. Global advances in health and medicine. 2012 Nov;1(5):20-.
51. Dan A, Swain R, Belonce S, Jacobs RJ, Belonce SE. Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review. Cureus. 2023 Apr 14;15(4).
52. Lowenthal R, Taylor M, Gidden JA, Heflin B, Lay Jr JO, Avaritt N, Tackett AJ, Urbaniak A. The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro. Biomedicine & Pharmacotherapy. 2023 May 1;161:114424.
53. Luk SU, Lee TK, Liu J, Lee DT, Chiu YT, Ma S, Ng IO, Wong YC, Chan FL, Ling MT. Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PloS one. 2011 May 16;6(5):e19804.
54. Yu ZT, Liu B, Mukherjee P, Newburg DS. Trametes versicolor extract modifies human fecal microbiota composition in vitro. Plant foods for human nutrition. 2013 Jun;68:107-12.
55. Shi LH, Balakrishnan K, Thiagarajah K, Ismail NI, Yin OS. Beneficial properties of probiotics. Tropical life sciences research. 2016 Aug;27(2):73.
Chaga
56. Kim YR. Immunomodulatory activity of the water extract from medicinal mushroom Inonotus obliquus. Mycobiology. 2005 Sep 1;33(3):158-62.
57. Choi SY, Hur SJ, An CS, Jeon YH, Jeoung YJ, Bak JP, Lim BO. Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate. BioMed Research International. 2010 Jan 1;2010.
58. Nakajima Y, Sato Y, Konishi T. Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga). Chemical and Pharmaceutical Bulletin. 2007 Aug 1;55(8):1222-6.
59. Halliwell B. Antioxidants: the basics-what they are and how to evaluate them. Advances in pharmacology. 1996 Jan 1;38:3-20.
60. Cui Y, Kim DS, Park KC. Antioxidant effect of Inonotus obliquus. Journal of Ethnopharmacology. 2005 Jan 4;96(1-2):79-85.
61. Wang J, Wang C, Li S, Li W, Yuan G, Pan Y, Chen H. Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway. Biomedicine & Pharmacotherapy. 2017 Nov 1;95:1669-77.
62. Sun JE, Ao ZH, Lu ZM, Xu HY, Zhang XM, Dou WF, Xu ZH. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. Journal of Ethnopharmacology. 2008 Jun 19;118(1):7-13.
Shiitake
63. Diao BZ, Jin WR, Yu XJ. Protective effect of polysaccharides from Inonotus obliquus on streptozotocin-induced diabetic symptoms and their potential mechanisms in rats. Evidence-Based Complementary and Alternative Medicine. 2014 Jan 1;2014.
64. Liang L, Zhang Z, Sun W, Wang Y. Effect of the Inonotus obliquus polysaccharides on blood lipid metabolism and oxidative stress of rats fed high-fat diet in vivo. In2009 2nd International Conference on Biomedical Engineering and Informatics 2009 Oct 17 (pp. 1-4). IEEE.
65. FoodData Central [Internet]. fdc.nal.usda.gov. Available from: https://fdc.nal.usda.gov/fdc-app.html#/food-details/168436/nutrients. [Accessed on Aug 25, 2023].
66. Guillamón E, García-Lafuente A, Lozano M, Rostagno MA, Villares A, Martínez JA. Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia. 2010 Oct 1;81(7):715-23.
67. Blumberg DL. Vitamins & Nutrients for Healthy Skin [Internet]. WebMD. Available from: https://www.webmd.com/beauty/nutrients-for-healthy-skin. [Accessed on Aug 25, 2023].
68. Dell'Acqua G, Schweikert K. Panthenyl triacetate transformation, stimulation of metabolic pathways, and wound-healing properties in the human skin. Journal of Cosmetic Science. 2012 Jan 1;63(1):1-3.
69. Saini K, Mysore V. Role of vitamin D in hair loss: A short review. Journal of cosmetic dermatology. 2021 Nov;20(11):3407-14.
70. Xu X, Yang J, Luo Z, Zhang X. Lentinula edodes-derived polysaccharide enhances systemic and mucosal immunity by spatial modulation of intestinal gene expression in mice. Food & function. 2015;6(6):2068-80.
71. Dai X, Stanilka JM, Rowe CA, Esteves EA, Nieves Jr C, Spaiser SJ, Christman MC, Langkamp-Henken B, Percival SS. Consuming Lentinula edodes (Shiitake) mushrooms daily improves human immunity: A randomized dietary intervention in healthy young adults. Journal of the American College of Nutrition. 2015 Nov 2;34(6):478-87.
72. Xu X, Yang J, Ning Z, Zhang X. Lentinula edodes-derived polysaccharide rejuvenates mice in terms of immune responses and gut microbiota. Food & function. 2015;6(8):2653-63.
73. Sukmawati IK, Yuniarto A, Alighita W. Antibacterial Activity of Extract and Fraction From Shitake Mushroom (Lentinula edodes) Against Acne Bacteria. Indonesian Journal of Pharmaceutical Science and Technology. 2019;6(1):36-45.
74. Hyde KD, Bahkali AH, Moslem MA. Fungi—an unusual source for cosmetics. Fungal diversity. 2010 Jul;43:1-9.
75. Yang H, Hwang I, Kim S, Hong EJ, Jeung EB. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Experimental and therapeutic medicine. 2013 Dec 1;6(6):1409-13.
76. Phillips KM, Ruggio DM, Horst RL, Minor B, Simon RR, Feeney MJ, Byrdwell WC, Haytowitz DB. Vitamin D and sterol composition of 10 types of mushrooms from retail suppliers in the United States. Journal of Agricultural and Food Chemistry. 2011 Jul 27;59(14):7841-53.
77. Bak WC, Park JH, Park YA, Ka KH. Determination of glucan contents in the fruiting bodies and mycelia of Lentinula edodes cultivars. Mycobiology. 2014 Sep 1;42(3):301-4.
78. Kabir Y, YAMAGUCHI M, KIMURA S. Effect of Shiitake (Lentinus edodes) and Maitake (Grjfola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. Journal of nutritional science and vitaminology. 1987;33(5):341-6.
Cordyceps
79. Vasiljevic J, Zivkovic L, Cabarkapa A, Bajic V, Djelic N, Spremo-Potparevic B. Cordyceps sinensis: Genotoxic Potential in Human Peripheral Blood Cells and Antigenotoxic Properties Against Hydrogen Peroxide by Comet Assay. Alternative Therapies in Health & Medicine. 2016 Sep 3;22.
80. Tan NZ, Barger JL, Zhang Y, Ferguson SB, Wu ZM, Prolla TA, Bartlett M, Zhu JS. The lifespan-extending effect of Cordyceps sinensis Cs-4 in normal mice and its molecular mechanisms. FASEB J. 2011 Apr 1;25:599-1.
81. Zou Y, Liu Y, Ruan M, Feng X, Wang J, Chu Z, Zhang Z. Cordyceps sinensis oral liquid prolongs the lifespan of the fruit fly, Drosophila melanogaster, by inhibiting oxidative stress. International Journal of Molecular Medicine. 2015 Oct 1;36(4):939-46.
82. Panda AK. Tracing historical perspective of Cordyceps sinensis-an aphrodisiac in Sikkim Himalaya. Indian J. Hist. Sci. 2010;2:189-98.
83. Kearney JT. Training the Olympic athlete. Scientific American. 1996 Jun 1;274(6):52-63.
84. Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of dietary supplements. 2017 Jan 2;14(1):42-53.
85. Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cs-4®(Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. The Journal of alternative and complementary medicine. 2010 May 1;16(5):585-90.
86. Zhang HW, Lin ZX, Tung YS, Kwan TH, Mok CK, Leung C, Chan LS. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database of Systematic Reviews. 2014(12).
87. Gao J, Lian ZQ, Zhu P, Zhu HB. Lipid-lowering effect of cordycepin (3'-deoxyadenosine) from Cordyceps militaris on hyperlipidemic hamsters and rats. Yao xue xue bao= Acta pharmaceutica Sinica. 2011 Jun 1;46(6):669-76.
88. Guo P, Kai Q, Gao J, Lian ZQ, Wu CM, Wu CA, Zhu HB. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. Journal of pharmacological sciences. 2010;113(4):395-403.
89. Mehra A, Zaidi KU, Mani A, Thawani V. The health benefits of Cordyceps militaris—A review. Kavaka. 2017;48(1):27-32.
90. Lin BQ, Li SP. Cordyceps as an herbal drug. Herbal medicine: biomolecular and clinical aspects. 2011 Mar 28;5.
91. Kuo YC, Tsai WJ, Shiao MS, Chen CF, Lin CY. Cordyceps sinensis as an immunomodulatory agent. The American Journal of Chinese Medicine. 1996;24(02):111-25.
92. Chiu CP, Liu SC, Tang CH, Chan Y, El-Shazly M, Lee CL, Du YC, Wu TY, Chang FR, Wu YC. Anti-inflammatory cerebrosides from cultivated Cordyceps militaris. Journal of agricultural and food chemistry. 2016 Feb 24;64(7):1540-8.
93. Hsu CH, Sun HL, Sheu JN, Ku MS, Hu CM, Chan Y, Lue KH. Effects of the immunomodulatory agent Cordyceps militaris on airway inflammation in a mouse asthma model. Pediatrics & Neonatology. 2008 Oct 1;49(5):171-8.